Drug recall · January 19, 2022
Metoprolol Tartrate Tablets recall
Why: Complaint received of foreign matter (metal) embedded in tablet.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distributed by: TruPharma, LLC. Tampa, FL 33609; Manufactured by: Rubicon Research Prvate Limited Ambernath, Dist. Thane, 421506 India. NDC 52817-360-00
- Lots / codes
Batch # 210211H1, Exp. date FEB 2024
- Quantity
- 3,684 1000-count bottles
- Company
- Rubicon Research Private Limited, Ambernath, N/A
- Distribution
- Product was distributed to one distributor who may have distributed the product further nationwide.
- Initiated
- December 31, 2021 · Voluntary: Firm initiated
- Classified
- January 7, 2022
- Reported
- January 19, 2022
- Ended
- November 4, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metoprolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.